Autologous stem cell transplantation has augmented treatment successes. However, high-dose chemotherapy is still accompanied by dose-limiting toxicities, for example, severe mucositis. Mucosal lesions serve as portals of entry for infections. In order to reduce the oral microbial burden, we prospectively evaluated the microbiological impact of a complex regimen of mouth rinses consisting of concomitantly applied polyene antifungals, povidone-iodine, chlorhexidine, sage tea, and prophylactic ciprofloxacin and fluconazole. A total of 15 patients were enrolled into this longitudinal evaluation. Colony-forming units (CFU) were quantitated from saliva, buccal and palatinal swabs during high-dose chemotherapy and autologous stem cell transplantation. The number of CFU did not show any significant changes after initiation of the mouth rinses and the prophylactic antibiotics. The median CFU count was 268 Â 10 6 /ml saliva before chemotherapy and decreased after initiation of intravenous antibiotics only. Neither prophylactic nor therapeutic antifungals significantly reduced the number of cultures positive for yeasts. Since 90% of our patients had febrile neutropenia at some time point during the observation period, the approach evaluated cannot be recommended as prophylaxis of febrile neutropenia as such.
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Certain high-dose chemotherapies including the BEAM (Table 1) regimen regularly result into grade 3 stomatitis according to the National Cancer Institutes Common Toxicity Criteria. 8, 9 In patients with stomatitis, the general condition is impaired by frank pain of the mouth and pharynx. 10 Furthermore, mucosal lesions have been shown to serve as portals of entry for infectious agents. This holds true for bacteria as well as fungi and other microorganisms of the oral microflora. 11, 12 Infections of the oral cavity may also play an important role in the development and persistence of mucositis. 13 Moreover, gram-negative bacilli and their endotoxines are considered possible pathogenetic factors, too. 13 Different approaches to reduce the oral burden of microorganisms have been evaluated. 10, 12 Antibiotic prophylaxis has been discussed, but due to the worldwide increase in resistance among bacterial pathogens, antibiotic prophylaxis, in general, is an issue of utmost controversy. 14 Currently, it is even discouraged by scientific societies. 15 The use of nonantibiotic mouth rinses is assumed not to carry a relevant risk of enhancing bacterial resistance. Currently, various mouth rinses are used in order to reduce the microbial flora of the mouth and/or the gastrointestinal tract. Among others, popular mouth rinses may contain chemically defined disinfectants, systemically active antibiotics, topical antifungals, growth factors, or naturally occurring plant extracts and teas. 16 Some, but not all of these have proven efficacy in terms of attenuating stomatitis grade and oral pain. 17 In general, the clinical intention of prophylactic mouth rinses is to reduce the mucosal microbial burden, thus preventing microorganisms from translocating into submucosal tissue and initiating systemic infection. We prospectively evaluated the microbiological impact of an elaborate regimen of mouth rinses consisting of polyene antifungals, povidone-iodine, chlorhexidine, and sage tea and concomitant antibiotic prophylaxis on the mucosal microbial burden.
Patients and methods
All patients enrolled were treated for relapsed or primary progressive Hodgkin's or high-grade Non-Hodgkin's lymphoma. Inclusion criteria were: autologous peripheral blood stem cell transplantation with preceding myeloablative BEAM chemotherapy (Table 1) , adult age, and signed informed consent. The following criteria led to exclusion: allergy to one of the study drugs, or a Karnofsky index o70.
Days (d) of examination and sampling were: initiation of myeloablative BEAM chemotherapy (d À6), peripheral blood stem cell transplantation (d 0), d þ 6, and d þ 14. In preliminary examinations of patients who underwent the same BEAM chemotherapy as our study population, we observed the highest grade of mucositis around d þ 6, whereas on d þ 14 in most patients mucositis had disappeared or was only residual.
Anti-infective prophylaxis
All patients received prophylactic anti-infective treatment with oral ciprofloxacin 500 mg b.i.d., fluconazole 400 mg q.d., and mouth rinses with polyene antifungals (amphotericin B 0.4 g or nystatin 500.000 IE), povidone-iodine (75 mg/ml), chlorhexidine (1 mg/ml), and sage tea up to 10 times daily. Prophylaxis started with the myeloablative chemotherapy. Patients were repeatedly encouraged to use the mouth rinses directly observed at least 6 times daily.
Sampling was carried out in the early morning before mouth rinses were used. Patients chewed on a paraffin block for 60 s to increase the amount of saliva to be collected. Saliva and buccal and palatinal swabs were taken by the investigators. On the same occasion, the severity of mucositis was determined using the Oral Assessment Guide, an eight-item instrument evaluating voice, swallowing, lips, tongue, saliva, mucosa, gingiva, and teeth. 18 Oral pain was self-assessed using a 0-100 visual analog scale (results not shown).
The volume of stimulated saliva was determined at bedside. Then, Ringer's lactate solution was added to each sample to get a volume of 3 ml of which 2 ml was given to the microbiological laboratory within 1 h. Swabs were immersed for 1 h in 2 ml Ringer's lactate solution. In the laboratory, the samples were diluted stepwise in log 10 steps in physiological saline solution. Of the undiluted sample and of every dilution step (10 À1 -10
À5
), 100 ml aliquots were cultured on blood agar under normal atmospheric conditions to determine the number of aerobic growing bacteria. Of the undiluted sample and of the dilution steps (10 À1 -10 À3 ), 100 ml was cultured on special media under normal, anaerobic or CO 2 -enriched atmospheric conditions: Endo agar for the detection of gram-negative rods (enterobacteriaceae, nonfermenters), chocolate agar with bacitracin for fastidious gram-negative rods (Haemophilus spp., Actinobacillus spp.), Rogosa s agar for lactobacilli, SM s agar for the streptococcus mutans group, KV agar for the detection of anaerobic gram-negative rods, CX, a special agar for actinomycetes, and chromogenic agar for yeasts. After 48 h incubation for media in a normal atmosphere, 4 days for those in CO 2 -enriched atmosphere, and 7 days for those in anaerobic atmosphere, the morphologically different CFU were counted and the number per millilitre was determined. Identification was done with standard laboratory methods. Establishing sensitivity and specificity of the investigation technique as well as the controlling of the media lots are regulated according to the quality management system of the ISO-certified laboratory.
Results
Of the 15 patients participating, six (40%) were female subjects. Age ranged from 22 to 62 years (median 48 years). Two (13.3%) patients could not be examined on d þ 6. One was somnolent and thus unable to cooperate, another patient refused the examination due to severe oral pain. For all other patients, complete data sets were obtained. On d þ 6, patients were not able to chew without massive pain, therefore only unstimulated saliva was collected.
Adherence to prophylaxis
All patients began prophylaxis with oral fluconazole and ciprofloxacin. Four patients aborted ciprofloxacin on d À2. A total of 14 (93.3%) patients required empiric antibiotic therapy for febrile neutropenia, in 13 intravenous treatment started between d 0 and d þ 6, one patient began before d 0. In total 14 (93.3%) patients chose oral amphotericin B, of these one patient took amphotericin B plus nystatin for 18 days, one patient started with both and discontinued amphotericin B after 6 days due to its unfavourable taste, three patients substituted amphotericin B before d 0 with nystatin. Only one patient used nystatin as the only antifungal mouth rinse during the whole episode. Two patients ended povidone-iodine prior to the end of treatment (d þ 8 and d þ 1), three (20%) stopped prophylaxis with chlorhexidine (one on d þ 12, two on d þ 4), and one (6.6%) patient did not use sage tea during the whole study period. Overall, 10 (66.7%) patients received a full prophylactic course of a polyene antifungal, povidoneiodine, chlorhexidine, and sage tea, while five (33.3%) prematurely discontinued the prophylactic regimen.
Longitudinal quantitation of CFU
The results from swabs and saliva were almost identical. The overall number of CFU/ml saliva did not show any significant changes after initiation of the mouth rinses and systemic ciprofloxacin and fluconazole (r ¼ 0.512; Table 2 ). In general, gram-positive bacterial counts were approximately 10 times higher than gram-negatives. The median CFU count was 268 Â 10 6 (range 23-1937 Â 10 6 ) CFU/ml saliva on d À6 and 222 Â 10 6 CFU/ml (range 10.3-3120 Â 10 6 ) on d 0. Intravenous antibiotic therapy for ). In only one patient, there was no need for intravenous antibiotic treatment, in his saliva the CFU/ml increased from 292 Â 10 6 on d À6 to 457 Â 10 6 on d 0, to 799 Â 10 6 on d þ 6. In Figure 1 , the course of salivary CFU counts is given for each study participant separately.
Gram-negative bacteria
From 12 of 172 (7%) samples, gram-negative bacilli were isolated. A total of 10 of these (83.3%) were taken from one patient only. The bacteria were identified as Escherichia coli. The number of E. coli CFU in his saliva increased from 23 CFU/ml on d À6, to 1.38 Â 10 6 /ml on d 0, to 219 Â 10 6 /ml on d þ 6. It decreased to 0.049 Â 10 6 /ml on d þ 14; intravenous antibiotic treatment for fever of unknown origin in this patient was begun on day þ 2. The other gram-negative isolates were taken from two different patients as follows: nonfermenting rods on a d À6 examination, and Klebsiella sp. once on d þ 14. The CFU count was low in both samples.
Yeasts
There was no statistically significant difference in fungal colonization between d À6 and d 0 (r ¼ 0.334) nor when comparing d 0 and d þ 6 (r ¼ 0.523). Table 3 gives the numbers of positive cultures for fungal growth on a chromogenic agar for saliva samples.
Discussion
Bacterial infection of the oral cavity is considered one of the major pathogenetic factors in the development of severe oral mucositis. Therefore, many prophylactic regimens aimed at the prevention of oral infection by using different anti-infective mouth rinses. [19] [20] [21] [22] [23] [24] [25] The anti-infectives used in our study, that is, PVP, chlorhexidine, polyenes, and sage tea, have been examined in previous clinical trials. Some of these trials examined their effectiveness in preventing or alleviating mucositis. 21, 24 Other investigators evaluated the effect of mouth rinses on the bacterial and fungal colonization of the oral cavity. 19, 20, 26 The aim of this study was to assess whether a combination of local and systemic anti-infectives has the potential to reduce the oral microbial burden.
Chlorhexidine has been examined in a wide range of clinical backgrounds. Several studies observed a significant reduction in the duration and severity of oral mucositis. 21, 23 Other trials did not see an effect superior to a mouth rinse with water. 19, 24, 27 For the effect on the oral microflora, results are as heterogenous. Some studies found a reduction of potential pathogens, 19 and others an increase of gramnegative bacterial counts. 20, 22 A Cochrane analysis did not find chlorhexidine to be effective in the prevention of mucositis. 28 Another prophylactic approach is the use of a combination of amphotericin B, polymyxin B, and tobramycin given either as a paste 29 or as lozenges. [30] [31] [32] Whereas the application of lozenges reduced the severity of Table 2 Median bacterial colony-forming units per ml saliva
CFU/ml saliva 2.60 Â 10 The present study aimed at the changes of the oral microflora following prophylactic treatment with a combination of different anti-infectives. We found that even through the frequent use of several mouth rinses, the longitudinal impact on bacterial and fungal colonisation was negligible. Prophylactic ciprofloxacin and fluconazole as well did not reduce the colonization. Instead, intravenous antibiotic treatment was followed by a significant reduction of the number of CFU.
In contrast to a recently proposed pathogenetic concept suggesting an overgrowth of gram-negative bacilli as a crucial step in the development of mucositis, 13 only a single patient in our study went through a gram-negative bacterial overgrowth, that is, by a quinolone-resistant E. coli. This patient adhered to the whole set of mouth rinses. In all other patients, gram-negative bacteria did not show a timely association with the development of mucositis.
Neither antifungal prophylaxis with polyene mouth rinses nor systemic treatment with antifungals did significantly change the number of cultures positive for Candida spp. (Figure 1 ). We did not observe a systemic fungal infection or high yeast counts in saliva.
Another intention for the use of prophylactic antimicrobial mouth rinses is the prevention of systemic infection. Since mucositis represents a severe damage of the protective anatomical barrier, prophylactic rinsing was hypothesized to lower the rate of bacteremia. The rate of bacteremia was as low as 20% in our patient group. However, since 90% of our patients had febrile neutropenia at some time point during the observation period, the approach evaluated can surely not be recommended as prophylaxis of neutropenic fever.
As a consequence of our trial, the prophylactic use of quinolone antibiotics and antifungals has been abandoned at our institution.
